SYNTA PHARMACEUTICALS CORP's ticker is and the CUSIP is 87162T906. A total of 3 filers reported holding SYNTA PHARMACEUTICALS CORP in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2015 | $25,000 | -78.8% | 69,700 | +2.7% | 0.00% | -100.0% |
| Q3 2015 | $118,000 | -26.2% | 67,900 | -5.4% | 0.00% | 0.0% |
| Q2 2015 | $160,000 | +79.8% | 71,800 | +55.7% | 0.00% | +100.0% |
| Q1 2015 | $89,000 | -29.9% | 46,100 | -3.8% | 0.00% | -50.0% |
| Q4 2014 | $127,000 | +71.6% | 47,900 | +94.7% | 0.00% | +100.0% |
| Q3 2014 | $74,000 | -81.8% | 24,600 | -75.3% | 0.00% | -83.3% |
| Q2 2014 | $407,000 | -42.8% | 99,500 | -39.7% | 0.01% | -50.0% |
| Q1 2014 | $711,000 | +22.8% | 164,900 | +49.2% | 0.01% | +33.3% |
| Q4 2013 | $579,000 | -40.5% | 110,500 | -28.3% | 0.01% | -52.6% |
| Q3 2013 | $973,000 | -7.3% | 154,200 | -26.7% | 0.02% | -26.9% |
| Q2 2013 | $1,050,000 | – | 210,400 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SPHERA FUNDS MANAGEMENT LTD. | 100,000 | $524,000 | 0.15% |
| GROUP ONE TRADING, L.P. | 110,500 | $579,000 | 0.01% |
| Citadel Advisors | 40,800 | $214,000 | 0.00% |